Chemoinformaics analysis of (3S,9R,10R)-heptadeca-4,6-diyne-3,9,10-triol
| Molecular Weight | 280.408 | nRot | 9 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 15 |
| Exact Molecular Weight | 280.204 | nRing | 0 |
| Solubility: LogS | -5.657 | nHRing | 0 |
| Solubility: LogP | 4.867 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 49.4662 |
| nHD | 3 | BPOL | 28.0898 |
| QED | 0.553 |
| Synth | 6.165 |
| Natural Product Likeliness | 2.926 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.763 |
| MDCK | 0.0000171 |
| BBB | 0.578 |
| PPB | 0.954976 |
| VDSS | 1.496 |
| FU | 0.0467355 |
| CYP1A2-inh | 0.178 |
| CYP1A2-sub | 0.679 |
| CYP2c19-inh | 0.202 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.204 |
| CYP2c9-sub | 0.612 |
| CYP2d6-inh | 0.159 |
| CYP2d6-sub | 0.74 |
| CYP3a4-inh | 0.705 |
| CYP3a4-sub | 0.264 |
| CL | 17.934 |
| T12 | 0.084 |
| hERG | 0.04 |
| Ames | 0.048 |
| ROA | 0.093 |
| SkinSen | 0.407 |
| Carcinogencity | 0.086 |
| EI | 0.168 |
| Respiratory | 0.931 |
| NR-Aromatase | 0.118 |
| Antiviral | Yes |
| Prediction | 0.782576 |